Modularly Designed Peptide Nanoprodrug Augments Antitumor Immunity of PD-L1 Checkpoint Blockade by Targeting Indoleamine 2,3-Dioxygenase

Xuexiang Han(Center for Excellence in Molecular Cell Science), Yiye Li(National Center for Nanoscience and Technology), Guangjun Nie(National Center for Nanoscience and Technology), Keman Cheng(National Center for Nanoscience and Technology), Huan Min(Zhengzhou University), Gregory J. Anderson(The University of Queensland), Ying Xu(Nankai University), Yinlong Zhang(National Center for Nanoscience and Technology), Lei Ren(Xiamen University), Ruifang Zhao(National Center for Nanoscience and Technology), Yazhou Wang(Technical University of Denmark), Xiao Zhao(Chinese Academy of Sciences)
Journal of the American Chemical Society
January 16, 2020
Cited by 131


Related Papers